David R Tabatadze
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.3MFederal grants as PI4 awards
5Patents grantedLatest May 13, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $3.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 2, 2021 | NIH | SBIR Phase II A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION | $1.2M | ZATA PHARMACEUTICALS, INC. |
| Feb 22, 2019 | NIH | SBIR Phase II A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION | $780K | ZATA PHARMACEUTICALS, INC. |
| May 11, 2017 | NIH | SBIR Phase II SELF-NEUTRALIZING OLIGONUCLEOTIDES WITH ENHANCED CELLULAR UPTAKE | $588K | ZATA PHARMACEUTICALS, INC. |
| May 27, 2016 | NIH | SBIR Phase II SELF-NEUTRALIZING OLIGONUCLEOTIDES WITH ENHANCED CELLULAR UPTAKE | $796K | ZATA PHARMACEUTICALS, INC. |
6 patents as inventor
- US 10173976ZATA PHARMACEUTICALS, INC.Jan 8, 2019
- US 10723755ZATA PHARMACEUTICALS, INC.Jul 28, 2020
- US 10738005ZATA PHARMACEUTICALS, INC.Aug 11, 2020
- US 11566042ZATA PHARMACEUTICALS, INC.Jan 31, 2023
- US 12297225ZATA PHARMACEUTICALS, INC.May 13, 2025
- US ZATA PHARMACEUTICALS, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#525
Awards as PI#566
Patents#25
Companies
- ZATA PHARMACEUTICALS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.